Advanced Proteome Therapeutics Corporation announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced net loss was USD 1.670 million compared to USD 119,845 a year ago. Basic loss per share from continuing operations was USD 0.05. For the nine months, net loss was USD 1.985 million compared to USD 251,490 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 1 a year ago.